fibrinogen has been researched along with Hyperprolactinemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalcze, K; Krysiak, R; Okopień, B | 1 |
| Basiak, M; Krysiak, R; Machnik, G; Okopień, B; Szkróbka, W | 1 |
| Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Ekman, B; Landberg, E; Lindahl, TL; Tillmar, L; Wahlberg, J | 1 |
| Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
| Akalin, S; Akpinar, I; Deyneli, O; Gözü, H; Haklar, G; Sezgin, O; Yavuz, D; Yildiz, E | 1 |
3 trial(s) available for fibrinogen and Hyperprolactinemia
| Article | Year |
|---|---|
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.
Topics: Adult; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperprolactinemia; Lipids; Metabolic Diseases; Middle Aged; Prolactin; Risk Factors | 2019 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
Topics: Adult; Blood Glucose; Bromocriptine; C-Reactive Protein; Cholesterol; Endothelium, Vascular; Estrogens; Female; Fibrinogen; Glucose Tolerance Test; Homocysteine; Hormone Antagonists; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Premenopause; Prolactin; Uric Acid; Vasodilation | 2003 |
3 other study(ies) available for fibrinogen and Hyperprolactinemia
| Article | Year |
|---|---|
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.
Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Fibrinogen; Glycated Hemoglobin; Hashimoto Disease; Humans; Hyperprolactinemia; Insulin Resistance; Lipoproteins, HDL; Prolactin; Risk Factors; Thyroiditis, Autoimmune; Uric Acid | 2023 |
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.
Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Glucose; Humans; Hyperprolactinemia; Pilot Projects; Prolactin; Risk Factors; Triglycerides; Uric Acid; Vitamin D; Vitamin D Deficiency; Vitamins | 2023 |
Effects of prolactin on platelet activation and blood clotting.
Topics: Adenosine Diphosphate; Adult; Biomarkers; Blood Coagulation; Blood Platelets; Carrier Proteins; Case-Control Studies; Female; Fibrinogen; Gene Expression; Humans; Hyperprolactinemia; Middle Aged; P-Selectin; Peptides; Platelet Activation; Prolactin; Receptors, Thrombin; Recombinant Proteins | 2013 |